Home > Financial Ratios > SHREE GANESH REMEDIES

SHREE GANESH REMEDIES
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for SHREE GANESH REMEDIES
Please provide your vote to see the results

SHREE GANESH REMEDIES Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2020Mar2019
   EV/Core EBITDA(x) 21.9219.544.094.88

What is the latest EV/Core EBITDA ratio of SHREE GANESH REMEDIES ?

The latest EV/Core EBITDA ratio of SHREE GANESH REMEDIES is 21.92 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202521.92
Mar202419.54
Mar20204.09
Mar20194.88

How is EV/Core EBITDA of SHREE GANESH REMEDIES Trending?

Years EV/Core EBITDA % Change
Mar2025 21.92
12.18
Mar2024 19.54
377.75
Mar2020 4.09
-16.19
Mar2019 4.88 -

Other Financial Ratios of SHREE GANESH REMEDIES


Compare EV/Core EBITDA ratio of peers of SHREE GANESH REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SHREE GANESH REMEDIES ₹557.6 Cr -4.4% -4.9% -39.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,708.0 Cr -2.9% -1.8% -2.5% Stock Analytics
DIVIS LABORATORIES ₹171,975.0 Cr 2.1% 0.2% 9.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹128,619.0 Cr 0.5% 2.2% 11.2% Stock Analytics
CIPLA ₹122,539.0 Cr 0.7% -0.8% 3.4% Stock Analytics
DR REDDYS LABORATORIES ₹106,741.0 Cr -0.1% 2.5% 2.5% Stock Analytics


SHREE GANESH REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SHREE GANESH REMEDIES

-4.4%

-4.9%

-39.3%

SENSEX

-0.4%

-0.3%

3.9%


You may also like the below Video Courses